SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-002229
Filing Date
2020-02-13
Accepted
2020-02-13 16:59:27
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 6038
  Complete submission text file 0001493152-20-002229.txt   7493
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4908 SOUTH ASHTON COURT SPOKANE WA 99223
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31791 | Film No.: 20611715